Biodesix announces fourth quarter and fiscal year end 2022 results and highlights

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the fourth quarter and year ended december 31, 2022 (fiscal 2022) and provided a corporate update. “it has been a productive year for biodesix, and i am extremely proud of our team's performance.
BDSX Ratings Summary
BDSX Quant Ranking